CBWTF - Auxly Cannabis Group Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.7185
-0.0315 (-4.20%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close0.7500
Open0.7433
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.7000 - 0.7589
52 Week Range0.5600 - 2.7000
Volume795,544
Avg. Volume2,161,498
Market Cap418.273M
Beta (3Y Monthly)11.71
PE Ratio (TTM)N/A
EPS (TTM)-0.0890
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • 4 Top Marijuana Penny Stocks for the Rest of 2018
    InvestorPlace19 hours ago

    4 Top Marijuana Penny Stocks for the Rest of 2018

    While it’s open to debate whether President Donald Trump made America great, the 2016 election did produce one undeniable result: it laid the foundation for cannabis-related businesses, thereby dramatically improving profitability potential for marijuana penny stocks. The federal government may just have to reconsider its stance on cannabis, which bodes very well for these four top marijuana penny stocks.

  • 3 Marijuana Stocks That Could Uplist Next
    Motley Fool4 days ago

    3 Marijuana Stocks That Could Uplist Next

    With five pot stocks having made the move to the NYSE or Nasdaq, and a sixth on the way, these three cannabis companies may be next.

  • Capacity Expansion and Partnerships Took Focus for Auxly Cannabis in Q3
    Motley Fool5 days ago

    Capacity Expansion and Partnerships Took Focus for Auxly Cannabis in Q3

    Although fundamental data remains light for a maturing marijuana industry, Auxly was very active in developing all three of its business verticals during the third quarter.

  • GlobeNewswire5 days ago

    Auxly Reports Q3 2018 Financial Results and Highlights Key Milestones

    Auxly Cannabis Group Inc. (TSX.V - XLY) (CBWTF) ("Auxly" or the "Company") has reported its financial and operational results for the three and nine months ended September 30th, 2018. Auxly’s management team has prioritized the following objectives for each of the Company’s business segments. Upstream: The Company continues to acquire cultivation capacity through the development of facilities in Canada and Uruguay.

  • GlobeNewswire16 days ago

    Auxly Announces Receipt of SENACLAFT Approval and Closing of Inverell S.A. Acquisition

    Auxly Cannabis Group Inc. (XLY.V) (CBWTF) ("Auxly" or the "Company") is pleased to announce that, further to the binding interim agreement announced on January 30th, 2018, the Company has received approval from the Secretaría Nacional para la Lucha contra el Lavado de Activos y el Financiamiento del Terrorismo (“SENACLAFT”), the government body overseeing foreign direct investments in Uruguay, for the Company’s acquisition of 80% of the issued and outstanding common shares (the “Transaction”) of Inverell S.A. (“Inverell”). Inverell is a federally licensed Cannabis Operator based in Montevideo, Uruguay. Led by Dr. Raúl Urbina, Inverell is a large-scale outdoor producer of hemp plants for CBD extraction operating on an initial footprint of approximately 300 hectares.

  • GlobeNewswire26 days ago

    Auxly Announces Cultivation and Retail Expansion Into Newfoundland & Labrador Through Strategic Partnership With Atlantic Cultivation

    Atlantic was founded by a team with a long-standing commitment to building opportunities in the province of Newfoundland and Labrador. Pillars of local industry, Christopher J. Hickman, Tom Collingwood Sr., Cynthia Crosbie and the entire Atlantic team lend to the project decades of unparalleled strategic leadership and oversight from diverse business environments. Atlantic’s collective of entrepreneurs have employed thousands of people across the province throughout the last five generations and look forward to playing a key role in the growth of the province's legal cannabis industry.

  • ACCESSWIRElast month

    Non-Opioid Pain Solutions Set to Make Investors Major Gains

    HENDERSON, NV / ACCESSWIRE / October 17, 2018 / Below are a few opportunities to help with one of America's largest problems: opioid addiction.While cannabis stocks have been receiving a lot of the attention ...

  • ACCESSWIRElast month

    Auxly Cannabis Business Model, Verticals and Operational Highlights

    NEW YORK, NY / ACCESSWIRE / October 15, 2018 / Traders News Source, a leading independent equity research, and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Auxly Cannabis Group Inc. (CBWTF), a company executing a business plan of building a vertically integrated global cannabis company with assets in each key segment of the cannabis value chain as the Canadian market enters legalization of recreational cannabis on October 17, 2018. As the start date for legal cannabis in Canada drew nearer the company shares rose to the current level of $.92 and have been as high as $1.10. The Company has continued to acquire cultivation capacity by developing cannabis cultivation facilities in Canada and internationally.

  • Better Marijuana Stock: Aurora Cannabis vs. Auxly Cannabis Group
    Motley Foollast month

    Better Marijuana Stock: Aurora Cannabis vs. Auxly Cannabis Group

    Is bigger better in a battle between these two Canadian marijuana stocks?

  • GlobeNewswire2 months ago

    Auxly Announces Strategic Investment in FSD Pharma

    Pursuant to the Transaction, Auxly has subscribed for $7,500,000 of publicly traded Class B Subordinate Voting Shares of FSD at a price of $1.00 per share (“Purchased Shares”). Proceeds from the financing will be used to fund the ongoing construction of the initial 220,000 square feet of cultivation space that Auxly and FSD are jointly developing at FSD’s 620,000 square foot facility (the “Facility”) in Cobourg, Ontario pursuant to the agreed upon construction and development budget, announced on July 3, 2018. Auxly retains a 49.9% stream of all cannabis and cannabis-derived products produced at the Facility, under partnership with Auxly, in perpetuity.

  • GlobeNewswire2 months ago

    REPEAT - Auxly Cannabis Group and Kaneh Bosm BioTechnology Inc. Announce Strategic Investment and Partnership and Name Change of KBB to ICC International Cannabis Corp.

    Auxly Cannabis Group Inc. (XLY.V) (CBWTF) ("Auxly" or the "Company") and Kaneh Bosm BioTechnology Inc. (CSE:KBB)(8K51.F)(KNHBF) ("Kaneh Bosm") are pleased to announce that Auxly has completed a strategic investment (the “Investment”) and has entered into a commercial rights agreement (the “Agreement” and together with the Investment, the “Transaction”) with Kaneh Bosm. Kaneh Bosm, through its subsidiaries, has a number of agreements and licences in place related to pharmaceutical distribution, wholesale importation, research and development, cultivation, production, storage, and exportation of cannabis and cannabis derivatives. In particular, Kaneh Bosm has agreements in place to supply a European-based pharmaceutical distributor with a network of 35,000 pharmacies in 16 countries, in addition to working interests in industrial hemp licences in Greece and wholly-owned licences to cultivate, produce, distribute, store, and export cannabis in Colombia, the Kingdom of Lesotho, and Denmark.

  • GlobeNewswire2 months ago

    Auxly Cannabis Group and Kaneh Bosm BioTechnology Inc. Announce Strategic Investment and Partnership and Name Change of KBB to ICC International Cannabis Corp.

    Auxly Cannabis Group Inc. (XLY.V) (CBWTF) ("Auxly" or the "Company") and Kaneh Bosm BioTechnology Inc. (CSE:KBB)(8K51.F)(KNHBF) ("Kaneh Bosm") are pleased to announce that Auxly has completed a strategic investment (the “Investment”) and has entered into a commercial rights agreement (the “Agreement” and together with the Investment, the “Transaction”) with Kaneh Bosm. Kaneh Bosm, through its subsidiaries, has a number of agreements and licences in place related to pharmaceutical distribution, wholesale importation, research and development, cultivation, production, storage, and exportation of cannabis and cannabis derivatives. In particular, Kaneh Bosm has agreements in place to supply a European-based pharmaceutical distributor with a network of 35,000 pharmacies in 16 countries, in addition to working interests in industrial hemp licences in Greece and wholly-owned licences to cultivate, produce, distribute, store, and export cannabis in Colombia, the Kingdom of Lesotho, and Denmark.

  • ACCESSWIRE2 months ago

    These Companies Bring Together Tech, Energy & Cannabis

    HENDERSON, NV / ACCESSWIRE / September 13, 2018 / The stock market is often divided into eleven major sectors representing key areas of the economy. Within each sector, there are a number of different ...

  • GlobeNewswire2 months ago

    Auxly Provides Operational Update on Uruguay-Based Inverell S.A.

    Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to provide the following operational update on the Company’s operations in Uruguay conducted through Inverell S.A. (“Inverell”). Inverell, founded and operated by Dr. Raul Urbina, a world-renowned expert in large scale outdoor cultivation, micropropagation, plant breeding and extraction operations, is a federally licensed cannabis operator based in Montevideo, Uruguay.

  • ACCESSWIRE2 months ago

    3 Canadian Marijuana Stocks Continuing to Trade Higher in September

    CORAL GABLES, FL / ACCESSWIRE / September 11, 2018 / Canadian marijuana stocks continue to lead the sector as the October deadline looms. In roughly 1 month Canada will begin legal sale of recreational marijuana across the country but this is just the beginning for the country. The move by Canada effectively makes the country the first G7 nation to legalize recreational cannabis use and further opens opportunities for companies in Canada to export marijuana as well.

  • GlobeNewswire2 months ago

    Auxly and Lotus Ventures Announce Investment and Signing of Definitive Long Term Purchase and Sale Agreement

    Auxly Cannabis Group Inc. (TSX.V - XLY) (CBWTF) ("Auxly" or the "Company") and Lotus Ventures Inc. (CSE – J)(“Lotus”) are pleased to announce the closing of an additional investment by Auxly to partially fund the completion of Lotus’ 22,500 square foot Facility (the “Facility”) in Armstrong, British Columbia (the “Transaction”). Lotus is a late stage applicant pursuant to the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) and anticipates completing the construction of the Facility by the end of September 2018. Pursuant to the Transaction, which is in addition to Auxly’s $1,000,000 subscription of common shares of Lotus completed in January 2018, Auxly advanced an additional $4,000,000 to Lotus to partially fund the completion of the Facility.

  • GlobeNewswire2 months ago

    Auxly Provides Corporate Update and Highlights 2018 Milestones

    Auxly Cannabis Group Inc. (TSX.V - XLY) (CBWTF) ("Auxly" or the "Company") is pleased to provide a corporate update in respect of its key milestones in 2018.  The Company continues to move forward and execute its business plan of building a vertically integrated global cannabis company. Originally founded with the primary intent of providing financing solutions to licensed producers and licensed producer applicants, the Company has since evolved into a global cannabis company with assets in each key segment of the cannabis value chain. The Company remains confident in its business strategy as the Canadian market enters legalization of recreational cannabis on October 17, 2018.

  • GlobeNewswire2 months ago

    Auxly Announces Definitive International Supply Agreement With Aphria

    Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX - CBWTF) ("Auxly" or the "Company") is pleased to announce that further to its previously announced interim supply agreement on January 17th, 2018, the Company, through its wholly owned subsidiary Dosecann Inc. (“Dosecann”), has entered into a definitive supply agreement (the “Agreement”) with Aphria Inc. (“Aphria”). Pursuant to the Agreement, Dosecann will have the option to purchase cannabis, including dried flower and cannabis oil (collectively, “Cannabis Products”) for distribution to certain international markets, including Mexico, Portugal, and Serbia, as well as a limited amount for distribution into the Canadian market.

  • GlobeNewswire2 months ago

    Auxly and Delta 9 Announce Strategic Investment and Supply Agreement

    Auxly Cannabis Group Inc. (TSX.V - XLY) (CBWTF) ("Auxly") and Delta 9 Cannabis Inc. (TSX.V -NINE) (“Delta 9”) are pleased to announce that the parties have entered into definitive agreement (the “Agreement”) whereby Auxly will make a strategic investment to fund the expansion of Delta 9’s licensed cannabis cultivation facility in Winnipeg, Manitoba (the “Facility”) and provide general working capital to Delta 9. Pursuant to the Agreement, Auxly has subscribed for 5,909,090 common shares of Delta 9 (each a “Delta 9 Share”) at a price of $2.75 per Delta 9 Share, representing a total investment of $16,250,000.

  • GlobeNewswire3 months ago

    Auxly Announces Completion of KGK Science Acquisition

    Auxly Cannabis Group Inc. (TSX.V - XLY) (CBWTF) ("Auxly" or the "Company") is pleased to announce that, further to its press release issued on August 21, 2018, it has completed its previously announced acquisition of all of the outstanding shares of KGK Science Inc. (“KGK”). KGK is a leading health and wellness focused private contract research organization based in London, Ontario, having provided a variety of clinical services to many of North America’s leading nutraceutical, natural health product and consumer packaged goods companies. The Company expects to leverage KGK’s expertise and research abilities to further the Company’s cannabinoid-based product development efforts through collaboration with the Company’s wholly owned subsidiary, Dosecann Inc.

  • GlobeNewswire3 months ago

    Auxly Announces Acquisition of Leading Canadian Contract Research Organization KGK Science

    Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to announce that it has entered into a share purchase agreement (the “Share Purchase Agreement”) with KGK Science Inc. (“KGK”) to acquire all of the issued and outstanding shares of KGK (the “KGK Shares”) for total consideration of $12,300,000 payable in cash and common shares of the Company. KGK is a leading health and wellness focused private contract research organization based in London, Ontario, and the Company expects to leverage KGK’s expertise and research abilities to further the Company’s product development efforts through collaboration with the Company’s wholly owned subsidiary, Dosecann Inc. (“Dosecann”).

  • The Craziest Marijuana Statistic From July
    Motley Fool3 months ago

    The Craziest Marijuana Statistic From July

    It was a rough month to be a pot-stock investor.